UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI - EP39

A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests

active, Most Current
Organization: CLSI
Publication Date: 1 November 2021
Status: active
Page Count: 144
scope:

This guideline establishes a definition of "surrogate sample" and an approach for selecting, preparing, and using these samples. It discusses surrogate sample:

• Composition

• Technical preparation

• Selection criteria

• Documentation and planning

• Use in specific performance study types

The intended users of this guideline are in vitro diagnostic (IVD) device developers, laboratorians, and regulators. This guideline does not describe performance study design, which is covered in other standards and guidelines (see CLSI document EP191).

Document History

EP39
November 1, 2021
A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests
This guideline establishes a definition of “surrogate sample” and an approach for selecting, preparing, and using these samples. It discusses surrogate sample: • Composition • Technical preparation...

References

Advertisement